Temporal Trends and Disparities in Nontuberculous Mycobacterial Mortality Among Older Adults in the United States: A CDC WONDER Analysis
Authors:
- Mustafa AmanMAMustafa Aman
- Daniyal Ali KhanDKDaniyal Ali Khan
- Zain Ul AbidinZAZain Ul Abidin
- Syed Haider Ali GardeziSGSyed Haider Ali Gardezi
- Mahnoor KhanMKMahnoor Khan
- Salaar Ahmad RaufSRSalaar Ahmad Rauf
- Syed Ali Tayyeb HasanSHSyed Ali Tayyeb Hasan
- Ali Bin Abdul JabbarAJAli Bin Abdul Jabbar
- Talha RiazTRTalha Riaz
Preprint
- 18 September 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction Nontuberculous mycobacteria (NTM) are increasingly recognized as significant pathogens, particularly in older and immunocompromised individuals, yet national data on NTM-associated mortality trends are limited and rely on older cohorts. Materials and Methods This cross-sectional study used CDC WONDER data (1999–2023) to assess NTM-related (ICD-10: A31) mortality trends in U.S. adults aged ≥ 45. Trends were stratified by gender, age, race, urbanization status, region, state, and place of death. Age-adjusted and crude mortality rates (AAMRs, CMRs) were calculated per million population. Trends were analyzed using Joinpoint regression to estimate annual and average annual percent changes (APCs, AAPCs). Results NTM-related mortality increased significantly from 1999 to 2023, with AAMR rising from 5.1 to 7.0 per million (AAPC = 1.38%*, 95% CI: 0.77–1.99). Of the 15,626 deaths, females accounted for 51.7%. However, males had higher AAMRs throughout. CMRs greatly increased across age groups, with the ≥ 85 cohort demonstrating the highest burden and rise in mortality (AAPC = 2.66%*, 95% CI: 2.03–3.49). White and Hispanic groups both demonstrated significantly rising AAMRs over time, with Black adults being the only group demonstrating the reverse trend (AAPC = − 1.40%*, 95% CI: − 2.44 to − 0.14). All regions except the West showed rising AAMRs, led consistently by the South, which increased from 6.2 to 8.6 (AAPC = 1.32%*, 95% CI: 0.69–1.85). Hawaii (12.2), South Carolina (9.8), and Vermont (9.0) recorded the highest AAMRs. Urban areas consistently exhibited higher AAMRs than rural ones. Conclusion NTM mortality is rising, with marked disparities by age, gender, race, and geography, underscoring the need for targeted public health interventions.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Trends in nontuberculous mycobacterial disease mortality based on 2000-2022 data from 83 countriesInternational Journal of Infectious Diseases, 2025
- Extrapulmonary nontuberculous mycobacterial infections: a guide for the general physicianClinical Medicine, 2024
- Global Epidemiology of Nontuberculous Mycobacterial Pulmonary DiseaseClinics in Chest Medicine, 2023
- The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysisScientific Reports, 2023
- TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic areaScientific Reports, 2022
- A NEW PERSPECTIVE OF LADY WINDERMERE SYNDROMEChest, 2021
- Environmental risk factors associated with pulmonary isolation of nontuberculous mycobacteria, a population-based study in the southeastern United StatesScience of The Total Environment, 2021
- Update on pulmonary disease due to non-tuberculous mycobacteriaInternational Journal of Infectious Diseases, 2016
- Nontuberculous Mycobacteria Infections in Immunosuppressed HostsClinics in Chest Medicine, 2015
- Ecology of Nontuberculous Mycobacteria—Where Do Human Infections Come from?Seminars in Respiratory and Critical Care Medicine, 2013